scholarly article | Q13442814 |
P50 | author | Dimitrios P Kontoyiannis | Q88469665 |
Thomas J Walsh | Q108430075 | ||
P2093 | author name string | Bruce E Bloom | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | emerging pathogen | Q108429945 |
P304 | page(s) | S1-4 | |
P577 | publication date | 2012-02-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis | |
P478 | volume | 54 Suppl 1 |
Q35491540 | Development of new strategies for early diagnosis of mucormycosis from bench to bedside |
Q37158654 | Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings |
Q28547234 | Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine |
Q38245340 | Host-iron assimilation: pathogenesis and novel therapies of mucormycosis |
Q38215757 | Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature. |
Q38017577 | Rhino-orbital-cerebral mucormycosis |
Q48878630 | Successful isavuconazole salvage therapy in a patient with invasive mucormycosis |
Q37077558 | Successful treatment of disseminated mucormycosis in a neutropenic patient with T-cell acute lymphoblastic leukaemia |
Q34687483 | Taxonomy of medically important fungi in the molecular era. |
Q38152678 | Update on mucormycosis pathogenesis |
Q36854025 | White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens |
Search more.